Marengo Therapeutics at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Marengo Therapeutics takes part in 5 sessions at SITC 2026 in Phoenix. Its program focuses on the regulation of new immuno-oncology agents and on building biotech companies, from small startups to midsize firms. It also covers how a new company raises funding, pitches itself and forms partnerships.
| Organization | SITC 2026 Attendance |
|---|---|
Marengo Therapeutics Cambridge, MA | |
Clinical-stage biotech developing antibodies that target TCR V-beta chains to selectively activate T cell subsets against cancer. | Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable
Workshop Wed Nov 4 4:10pm–4:55pm Workshop Wed Nov 4 4:55pm–5:00pm Session Thu Nov 5 12:00pm–1:30pm Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships
|
Instantly find 20 buyers from Marengo Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction